Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Bisaccia Lisa
  2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [CVS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP and Chief HR Officer
(Last)
(First)
(Middle)
ONE CVS DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2018
(Street)

WOONSOCKET, RI 02895
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2018   M   7,764 A $ 45.07 28,850 D  
Common Stock 10/01/2018   S(1)   7,764 D $ 80 21,086 D  
Common Stock 10/01/2018   M   13,770 A $ 54.53 34,856 D  
Common Stock 10/01/2018   S(1)   13,770 D $ 80 21,086 D  
Common Stock (restricted)               17,430 D  
ESOP Common Stock               592.536 I Direct
Stock Unit               30,783.5442 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $ 45.07 10/01/2018   M     7,764 04/02/2013(2) 04/02/2019 Common Stock 7,764 $ 0 0 D  
Stock Option $ 54.53 10/01/2018   M     13,770 04/01/2014(3) 04/01/2020 Common Stock 13,770 $ 0 0 D  
Phantom Stock Credits $ 1               (4)   (4) Common Stock 468.325   468.325 D  
Stock Option $ 74.29             04/01/2015(5) 04/01/2021 Common Stock 25,177   25,177 D  
Stock Option $ 102.26             04/01/2016(6) 04/01/2022 Common Stock 34,241   34,241 D  
Stock Option $ 104.82             04/01/2017(7) 04/01/2023 Common Stock 39,433   39,433 D  
Stock Option $ 78.05             04/03/2018(8) 04/03/2024 Common Stock 55,098   55,098 D  
Stock Option $ 62.21             04/01/2019(9) 04/01/2025 Common Stock 64,222   64,222 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Bisaccia Lisa
ONE CVS DRIVE
WOONSOCKET, RI 02895
      EVP and Chief HR Officer  

Signatures

 Lisa G. Bisaccia   10/03/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) All transactions were effected pursuant to a Rule 10b5-1 plan.
(2) Option became exercisable in four equal annual installments, commencing 4/2/2013.
(3) Option became exercisable in four equal annual installments, commencing 4/1/2014.
(4) Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.
(5) Option became exercisable in four equal annual installments, commencing 4/1/2015.
(6) Option became exercisable in four equal annual installments, commencing 4/1/2016.
(7) Option became exercisable in four equal annual installments, commencing 4/1/2017.
(8) Option became exercisable in four equal annual installments, commencing 4/3/2018.
(9) Option becomes exercisable in four equal annual installments, commencing 4/1/2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.